183 related articles for article (PubMed ID: 22313346)
1. Re-prescribing of causative drugs in persons discharged after serious drug-induced upper gastrointestinal bleeding.
Dall M; dePont Christensen R; Schaffalitzky de Muckadell OB; Lassen AT; Hallas J
Aliment Pharmacol Ther; 2012 Apr; 35(8):948-54. PubMed ID: 22313346
[TBL] [Abstract][Full Text] [Related]
2. Patterns in the use of low-dose acetylsalicylic acid and other therapies following upper gastrointestinal bleeding.
Sáez ME; González-Pérez A; Johansson S; Nagy P; García Rodríguez LA
Am J Cardiovasc Drugs; 2014 Dec; 14(6):443-50. PubMed ID: 25119521
[TBL] [Abstract][Full Text] [Related]
3. Poor awareness of preventing aspirin-induced gastrointestinal injury with combined protective medications.
Zhu LL; Xu LC; Chen Y; Zhou Q; Zeng S
World J Gastroenterol; 2012 Jun; 18(24):3167-72. PubMed ID: 22791953
[TBL] [Abstract][Full Text] [Related]
4. Prescribing of proton pump inhibitors for gastrointestinal bleeding prophylaxis in the Lebanese outpatient setting: patterns, compliance with guidelines and risks.
Soubra L; Issa M
Int J Pharm Pract; 2019 Aug; 27(4):386-392. PubMed ID: 30942513
[TBL] [Abstract][Full Text] [Related]
5. Selective serotonin reuptake inhibitors are associated with a modest increase in the risk of upper gastrointestinal bleeding.
Targownik LE; Bolton JM; Metge CJ; Leung S; Sareen J
Am J Gastroenterol; 2009 Jun; 104(6):1475-82. PubMed ID: 19491861
[TBL] [Abstract][Full Text] [Related]
6. Continuous proton pump inhibitor treatment decreases upper gastrointestinal bleeding and related death in rural area in Japan.
Miyamoto M; Haruma K; Okamoto T; Higashi Y; Hidaka T; Manabe N
J Gastroenterol Hepatol; 2012 Feb; 27(2):372-7. PubMed ID: 21793917
[TBL] [Abstract][Full Text] [Related]
7. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
[TBL] [Abstract][Full Text] [Related]
8. Only full adherence to proton pump inhibitors protects against drug-induced upper gastrointestinal bleeding.
Ruiz B; Aguirre U; Estany-Gestal A; Rodella L; Ruiz P; Figueiras A; Carvajal A; Ibáñez L; Conforti A; de Pancorbo MM; Vidal X; Martin LH; Aguirre C
Eur J Clin Pharmacol; 2018 Nov; 74(11):1503-1511. PubMed ID: 30043109
[TBL] [Abstract][Full Text] [Related]
9. Divergent trends of hospitalizations for upper and lower gastrointestinal bleeding based on population prescriptions of aspirin, proton pump inhibitors and Helicobacter pylori eradication therapy: Trends of upper and lower gastrointestinal bleeding.
Guo CG; Zhang F; Wu JT; Cheung KS; Li B; Law SYK; Leung WK
United European Gastroenterol J; 2021 Jun; 9(5):543-551. PubMed ID: 33956403
[TBL] [Abstract][Full Text] [Related]
10. Acid suppressants reduce risk of gastrointestinal bleeding in patients on antithrombotic or anti-inflammatory therapy.
Lin KJ; Hernández-Díaz S; García Rodríguez LA
Gastroenterology; 2011 Jul; 141(1):71-9. PubMed ID: 21458456
[TBL] [Abstract][Full Text] [Related]
11. Frequent prescribing of drugs with potential gastrointestinal toxicity among continuous users of non-steroidal anti-inflammatory drugs.
Helin-Salmivaara A; Huupponen R; Virtanen A; Lammela J; Klaukka T
Eur J Clin Pharmacol; 2005 Jul; 61(5-6):425-31. PubMed ID: 15952021
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitors reduce the long-term risk of recurrent upper gastrointestinal bleeding: an observational study.
Massó González EL; García Rodríguez LA
Aliment Pharmacol Ther; 2008 Sep; 28(5):629-37. PubMed ID: 18616644
[TBL] [Abstract][Full Text] [Related]
13. Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents.
de Abajo FJ; García-Rodríguez LA
Arch Gen Psychiatry; 2008 Jul; 65(7):795-803. PubMed ID: 18606952
[TBL] [Abstract][Full Text] [Related]
14. Impact of proton pump inhibitor treatment on gastrointestinal bleeding associated with non-steroidal anti-inflammatory drug use among post-myocardial infarction patients taking antithrombotics: nationwide study.
Schjerning Olsen AM; Lindhardsen J; Gislason GH; McGettigan P; Hlatky MA; Fosbøl E; Køber L; Torp-Pedersen C; Lamberts M
BMJ; 2015 Oct; 351():h5096. PubMed ID: 26481405
[TBL] [Abstract][Full Text] [Related]
15. Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding?
Tata LJ; Fortun PJ; Hubbard RB; Smeeth L; Hawkey CJ; Smith CJ; Whitaker HJ; Farrington CP; Card TR; West J
Aliment Pharmacol Ther; 2005 Aug; 22(3):175-81. PubMed ID: 16091054
[TBL] [Abstract][Full Text] [Related]
16. Risk of upper gastrointestinal bleeding from different drug combinations.
Masclee GM; Valkhoff VE; Coloma PM; de Ridder M; Romio S; Schuemie MJ; Herings R; Gini R; Mazzaglia G; Picelli G; Scotti L; Pedersen L; Kuipers EJ; van der Lei J; Sturkenboom MC
Gastroenterology; 2014 Oct; 147(4):784-792.e9; quiz e13-4. PubMed ID: 24937265
[TBL] [Abstract][Full Text] [Related]
17. Predictors and time trends in clopidogrel and proton pump inhibitor coprescription with low-dose acetylsalicylic acid.
Cea Soriano L; Bueno H; Johansson S; García Rodríguez LA
Pharmacoepidemiol Drug Saf; 2012 May; 21(5):463-9. PubMed ID: 22298501
[TBL] [Abstract][Full Text] [Related]
18. Physicians' Perceptions of Proton Pump Inhibitor Risks and Recommendations to Discontinue: A National Survey.
Kurlander JE; Rubenstein JH; Richardson CR; Krein SL; De Vries R; Zikmund-Fisher BJ; Yang YX; Laine L; Weissman A; Saini SD
Am J Gastroenterol; 2020 May; 115(5):689-696. PubMed ID: 32091419
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of ulcer bleeding risk factors in dual antiplatelet-treated patients after percutaneous coronary intervention.
Jensen BE; Hansen JM; Junker AB; Lassen JF; Jensen SE; Schaffalitzky de Muckadell OB
Dan Med J; 2015 Jun; 62(6):. PubMed ID: 26036886
[TBL] [Abstract][Full Text] [Related]
20. Adherence to guidelines for the prescribing of double and triple combinations of antithrombotic agents.
Warlé-Van Herwaarden MF; Roukens M; Pop GA; Lamfers EJ; De Smet PA; Kramers C
Eur J Prev Cardiol; 2014 Feb; 21(2):231-43. PubMed ID: 22684153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
